Essex-Lopresti injuries are often unrecognized acutely with resulting debilitating adverse effects. Persistent axial forearm instability may affect load transmission at both the elbow and wrist, resulting in significant pain. In the setting of both acute and chronic injuries metallic radial head arthroplasty has been advocated, however there is little information regarding their outcome. The purpose of this study was to assess the efficacy of a radial head arthroplasty to address both acute and chronic Essex-Lopresti type injuries. A retrospective review from 2006 to 2016 identified 11 Essex-Lopresti type injuries at a mean follow-up of 18 months. Five were diagnosed and treated acutely at a mean of 11 days (range, 8 to 19 days) from injury, while 6 were treated in a delayed fashion at a mean of 1.9 years (range, 2.7 months to 6.2 years) from injury with a mean 1.5 (range, 0 to 4) prior procedures. The cohort included 10 males with a mean age was 44.5 years (range, 28 to 71 years). A smooth stem, modular radial head arthroplasty was used in all cases. Outcomes included range of motion and radiographic findings such as ulnar variance, capitellar erosion, implant positioning and implant lucency using a modification of the method described by Gruen.
Femoroacetabular impingement (FAI) is a condition of the hip where there is a mismatch of the femoral head and hip acetabulum. This mismatch creates abnormal contact between the bones and causes hip pain which can lead to damage, and eventually osteoarthritis of the hip. The diagnosis and treatment of FAI has become one of the most popular clinical scenarios in orthopaedic surgery, with hip arthroscopy procedures increasing exponentially over the past five years. Surgical intervention usually involves correcting the existing deformities by reshaping the ball and socket (“osteoplasty” or “rim trimming”) so that they fit together more easily while repairing any other existing soft tissue damage in the hip joint (e.g. labral repair). Although correction of the misshaped bony anatomy and associated intra-articular soft tissue damage of the hip is thought to appease impingement and improve pain and function, the current evidence is based on small, observational, and low quality studies. A lack of definitive evidence regarding the efficacy of osteochondroplasty in treating FAI fueled the design and execution of the FIRST randomized controlled trial (RCT). FIRST evaluated the impact of surgical correction of the hip impingement morphology with arthroscopic osteochondroplasty versus arthroscopic lavage on pain, function, and quality of life in adults aged 18–50 years diagnosed with non-arthritic FAI at one year. FIRST was a large definitive RCT (NCT01623843) enrolling patients with FAI requiring surgical intervention across 11 international clinical sites. Participants were randomized to either arthroscopic osteochondroplasty (shaving of bone) or lavage (washing the joint of painful inflammation debris). The primary outcome was patient-reported pain within one year of the initial surgery measured using the Visual Analogue Scale (VAS). Secondary outcomes included function, health utility, and health-related quality of life using several general and hip-centric health questionnaires. An independent, blinded adjudication committee evaluated the quality of surgery, re-operations, and other patient complications. Patients and data analysts were blinded to the treatment groups. Two-hundred and twenty participants were enrolled into the FIRST trial over a six-year period (pilot phase: N=50, from 2012–2013 and definitive phase: N=170, from 2015–2018) at 11 clinical sites in Canada, Finland, and Denmark. The FIRST results will be released at the ISAKOS annual meeting as follows. The absolute difference in rate of pain reduction between groups was XX (95% CI: YY-YY, p=X). The mean differences of the Short-Form 12 (SF-12, MCS and PCS), Hip Outcome Score (HOS), International Hip Outcome Tool (iHOT-12), and EuroQol 5-Dimensions (EQ-5D) between groups are XX (95% CI: YY-YY, p=X)…, respectively.
INTRODUCTION. THA as primary treatment for displaced femoral neck fractures in elderly still remains a prominent concern. Overall dislocation rate after total hip arthroplasty (THA) is reported form 1∼5%. But, it is quiet different in situation of femur neck fracture in elderly. The THA is associated with higher rates of dislocation (8%∼11%) in eldery compared to hemiarthroplasty even though THA showed better clinical and functional scores. Recently resurgence about THA using DMC comes after improvement of manufacturing technology. The aim of this prospective multicenter study is to assess the rates of dislocation and re-operation for displaced femoral neck fractures in elderly with THA with Dual Mobility Cup (DMC) and to review systematically comparison of previous reports. Up to our knowledge, this is first report from asian conutry about the clinical outcomes THA using DMC for displaced femur neck fracture in elderly. METHODS. Prospective consecutive groups of patients treated for displaced femoral neck fractures by three surgeons at each three center were included. 131 hips underwent THA with DMC for acute displaced femoral neck fracture in patients aged older than 70 years. Data regarding rates of dislocation and re-operation were obtained by review of medical records. Additionally From 2009 which the US FDA first approved the DMC, the authors searched reports regarding to THA using DMC for displaced femur neck fracture in elderly using the MEDLINE including cases series and comparative studies with bipolar hemiarthroplasty and THA. Therefore, current report was compared with previous reports. RESULTS. The reports about THA using DMC for displaced femur neck fracture in elderly were limited. Most of them comes from European countries. Comparative study with THA from Sweden reported the dislocation rate of THA using DMC with average aged 75-year is 0%. In Denmark study, the bipolar hemiarthroplasty showed 14% of dislocation rate for femur neck fracture in patient aged 75 years but, THA using DMC is 4.6%. Two cases series from French reported about 1–4% in patients aged 80 years. In our multicenter study, dislocation occurred in 6/131 hips (4.6%) treated with total hip arthroplasty using DMC for displaced femur neck fracture over 70 years older patients.
Introduction. Ceramic total knee arthroplasty (TKA) was introduced as a new-generation of knee prostheses in clinical practice, and are expected to reduce polyethylene wear due to its resistance to abrasion and lubrication. In 1992, we developed a cruciate retaining LFA-I total knee prosthesis (KYOCERA Medical Co., Japan), which comprises an alumina ceramic femoral component and a titanium-alloy tibial component with a polyethylene insert. The purpose of this study was to evaluate clinical results in rheumatoid patients who were treated with the alumina-ceramic LFA-I prosthesis with a minimum 15-year follow-up period. Methods. A total of 70 primary TKAs were performed in 51 patients between 1993 and 1996 using the cemented alumina-ceramic LFA-I prosthesis. Sixteen of these patients (20 knees) had died by the time of this study, of causes unrelated to the index arthroplasty, and 11 patients (16 knees) were lost to the follow-up. The remaining 34 knees were clinically and radiographically evaluated in the present study. The average follow-up time was 16.7 years. The average age of the patients was 58.2 years at the time of the operation. The clinical assessment was conducted with the Hospital for Special Surgery Knee rating score and the Knee Society scoring system. The component alignment and bone-implant interface were evaluated according to the Knee Society Roentgenographic Evaluation System. Results. The cumulative survival rate for revision for any reason at 15 years was 94.1%. The mean postoperative range of motion was 115.3 degrees at the time of the most recent follow-up. The mean postoperative knee score was 90.1 and 84.7 using the Knee Society and the Hospital for Special Surgery rating systems, respectively.
Introduction.
Introduction and aims. Recently many implants for ankle arthroplasty have been developed around the world, and especially some mobile bearing, three-component implants have good results. Nevertheless, at our institution fixed two-component, semi-constrained alumina ceramic total ankle arthroplasty (TAA) with TNK Ankle had been performed since 1991 and led to improved outcomes. We report clinical results and in vivo kinematic analyses for TNK Ankle. Method. Between 1991 and 2006, total ankle arthroplasties with TNK Ankle were performed with 102 patients (106 ankles) with osteoarthritis at our institution. There were 91 women and 11 men. The mean age was 69 years and mean follow-up was 5.4 years. These cases were evaluated clinically and radiographically. Besides in vivo kinematics, in TNK Ankle was analysed using 3D-2D model registration technique with fluoroscopic images. Between 2007 and 2008, prospectively ten TAA cases examined with fluoroscopy at postoperative one year. Results. In clinical results, excellent were 48 cases, good were 31 cases, fair were 10 cases, poor were nine cases, and death and loss to follow-up were 10 cases.